Status: Recruiting
Study of DISC-0974-201 in Participants With IBD and Anemia
This is a Phase 2, multicenter, randomized, double-blind placebo-controlled study of DISC-0974 to evaluate safety, tolerability, and efficacy in participants with IBD and anemia of inflammation.
Participants needed: 21
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Disc Medicine, IncUpdated: Aug 3, 2026Locations: 14
Eligibility criteria
Aged ≥18 years at the time of signing informed consent. [+18]
Treatment within 2 days prior to screening with oral iron or iron-containing sup... [+32]